NMN (Nicotinamide Mononucleotide)
Research Reliability -
A direct NAD+ precursor that has become the flagship molecule of the modern longevity supplement movement.
Appetite
Mood
Sleep
NMN (Nicotinamide Mononucleotide)
Description
NMN sits one enzymatic step upstream of NAD+ in the salvage pathway and has become the flagship molecule of the longevity-supplement movement championed by researchers like David Sinclair. NAD+ is required for hundreds of cellular reactions, including DNA repair via PARP enzymes and the activity of sirtuins, the so-called "longevity genes" implicated in stress resistance and metabolic health. Levels decline roughly 50% between age 20 and 60, which biohackers link to fatigue, slower recovery, and accelerated aging. NMN was excluded from the U.S. dietary supplement definition in 2022 and reinstated as lawful in September 2025, so sourcing from a reputable, third-party-tested manufacturer matters given years of inconsistent quality on the open market.
Effects
First 2 weeks
no felt effect for most
Weeks 2–4
Long term
How It Feels
Most people feel nothing; a subset report steadier energy over a few weeks, which is hard to separate from expectation. This is taken as a bet on NAD+ biology and aging, measured on labs rather than sensation. The long-term human evidence is still being built.
Evidence
Evidence Strength
Preliminary (limited / small human data)
Caveats
NMN reliably raises NAD+ levels, but the human trial evidence for downstream clinical benefits (versus biomarker changes) remains limited. NMN's U.S. regulatory status as a dietary supplement has changed more than once in recent years; confirm current status before making supplement-category claims.
Usage
Commonly Referenced Starting Amount
250 mg/day
Commonly Referenced Amount
250–900 mg/day is the range used in the human trials that have measured it, which reliably show it raises NAD+ levels
Referenced Upper Limit
No upper limit has been established. Important honesty note: raising NAD+ and producing an anti-aging or lifespan benefit in humans are two different claims — only the first has real trial support so far. The FDA has also taken the position that NMN may be excluded from the dietary-supplement category pending a drug-investigation question, so its regulatory status is unsettled
Onset
2–4 weeks (NAD+ levels)
Biomarkers to Track
Subjective
(Daily)
Energy and afternoon fatigue (1–10)
Exercise recovery speed
Skin and hair vitality
Objective
(Quarterly)
Whole blood NAD+ level (specialty test)
Fasting glucose and HbA1c
Grip strength (sarcopenia proxy)
Generally well tolerated in studies, but a longevity bet with human outcome data still developing. Note its regulatory status has been contested in the US.
Pregnant and breastfeeding women, and cancer patients should discuss it first.
Expecting a felt effect, and paying premium prices for unverified products.
Disclaimer
This information is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any new supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition.
Yoshino M et al. (2021). Science, 372(6547), 1224-1229. RCT (NMN and muscle insulin sensitivity in prediabetic postmenopausal women). PMID: 33888596. DOI: 10.1126/science.abe9985.
MORE SUPPLEMENTS LIKE THIS
